- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07945704
GLP-1 RAs and Dietary Intake and Body Composition
Longitudinal Effects of GLP-1 Receptor Agonists on Dietary Intake and Body Composition
To assess longitudinal changes in dietary intake, body composition and metabolism with GLP-1 RA use.
Studieöversikt
Status
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studieorter
-
-
Ohio
-
Athens, Ohio, Förenta staterna, 45701
- Rekrytering
- Exercise Physiology Lab
-
Kontakt:
- Angela Hillman, PhD
- Telefonnummer: 740-593-0153
- E-post: hillman@ohio.edu
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
People taking GLP-1 RA medications
Beskrivning
Inclusion Criteria:
- Currently taking GLP-1 medications and have been taking them for less than a month
- between the ages of 18-75 years
Exclusion Criteria:
- Not between the ages of 18-75 years
- Not currently using GLP-1 medications
- Have been using GLP-1 medications for 1 month or longer
- Currently pregnant
- Currently nursing
- Bariatric surgery in the last 3 months
- Have an implanted cardiac device, such as a pacemaker or defibrillator
- Not willing to have a DEXA (full body x-ray) at the start and end of the 12 week study period
- Not willing to have a bioelectrical impedance body composition scan at the start and every 2 weeks during the 12 week study period
- Not willing to have your resting metabolism measured at the start and end of the 12 week study period
- Not willing to track your diet at the beginning and end of the study
- Not willing to complete surveys assessing depression, food noise and disordered eating
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
change in body mass
Tidsram: 12 weeks
|
change in body weight measured in kg using BIA and DEXA |
12 weeks
|
|
change in skeletal muscle mass
Tidsram: 12 weeks
|
change in skeletal muscle mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in body fat mass
Tidsram: 12 weeks
|
change in body fat mass measured in kg using BIA and DEXA |
12 weeks
|
|
change in resting metabolism
Tidsram: 12 weeks
|
change in resting metabolic rate in kcals/day as measured via indirect calorimetry |
12 weeks
|
|
change in substrate utilization rates
Tidsram: 12 weeks
|
change in resting carbohydrate and fat oxidation rates as measured via indirect calorimetry |
12 weeks
|
|
change in bone mineral content
Tidsram: 12 weeks
|
change in bone mineral content measured via DEXA and BIA |
12 weeks
|
|
change in bone mineral density
Tidsram: 12 weeks
|
change in bone mineral density measured via DEXA |
12 weeks
|
|
change in total daily caloric intake
Tidsram: 12 weeks
|
change in total daily caloric intake measured via 24 hour food diary |
12 weeks
|
|
change in daily carbohydrate intake
Tidsram: 12 weeks
|
change in daily carbohydrate intake measured via 24 hour food diary |
12 weeks
|
|
change in daily fat intake
Tidsram: 12 weeks
|
change in daily fat intake measured via 24 hour food diary |
12 weeks
|
|
change in daily protein intake
Tidsram: 12 weeks
|
change in daily protein intake measured via 24 hour food diary |
12 weeks
|
|
change in daily mineral intake
Tidsram: 12 weeks
|
change in daily mineral intake measured via 24 hour food diary |
12 weeks
|
|
change in daily vitamin intake
Tidsram: 12 weeks
|
change in daily vitamin intake measured via 24 hour food diary |
12 weeks
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- IRB-FY26-568
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .